User:Mr. Ibrahem/Miglitol
Appearance
Clinical data | |
---|---|
Trade names | Glyset |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601079 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth (tablets) |
Drug class | α-glucosidase inhibitor[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Dose-dependent |
Protein binding | Negligible (<4.0%) |
Metabolism | Nil |
Elimination half-life | 2 hours |
Excretion | Kidney (95%) |
Identifiers | |
| |
Chemical and physical data | |
Formula | C8H17NO5 |
Molar mass | 207.226 g·mol−1 |
3D model (JSmol) | |
Density | 1.458 g/cm3 |
Melting point | 114 °C (237 °F) |
| |
| |
(verify) |
Miglitol, sold under the brand name Glycet, is a medication used to treat type 2 diabetes.[1] It is taken by mouth.[1] It is used together with diet and exercise.[1]
Common side effects include diarrhea, abdominal pain, and increased intestinal gas.[1] Well there is no evidence of harm in pregnancy, such use has not been well studied.[2] It is an α-glucosidase inhibitor which decreases the break down complex carbohydrates into glucose.[1]
Miglitol was approved for medical use in the United States in 1996.[1] It is available as a generic medication.[3] In the United States it costs about 24 USD per month as of 2021.[3]
References[edit]
- ^ a b c d e f g h i j "Miglitol Monograph for Professionals". Drugs.com. Archived from the original on 14 August 2020. Retrieved 18 November 2021.
- ^ "Miglitol (Glyset) Use During Pregnancy". Drugs.com. Archived from the original on 3 December 2020. Retrieved 18 November 2021.
- ^ a b "Miglitol Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 18 November 2021.